| A depression rating scale for schizophrenics D Addington, J Addington, B Schissel Schizophrenia research 3 (4), 247-251, 1990 | 1550 | 1990 |
| Assessing depression in schizophrenia: the Calgary Depression Scale D Addington, J Addington, E Maticka-Tyndale The British journal of psychiatry 163 (S22), 39-44, 1993 | 1385 | 1993 |
| A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients G Chouinard, B Jones, G Remington, D Bloom, D Addington, ... Journal of clinical psychopharmacology 13 (1), 25-40, 1993 | 1254 | 1993 |
| Reliability and validity of a depression rating scale for schizophrenics D Addington, J Addington, E Maticka-Tyndale, J Joyce Schizophrenia research 6 (3), 201-208, 1992 | 868 | 1992 |
| Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis TH McGlashan, RB Zipursky, D Perkins, J Addington, T Miller, SW Woods, ... American Journal of Psychiatry 163 (5), 790-799, 2006 | 750 | 2006 |
| Facial affect recognition and information processing in schizophrenia and bipolar disorder J Addington, D Addington Schizophrenia research 32 (3), 171-181, 1998 | 701 | 1998 |
| Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol SE Purdon, BDW Jones, E Stip, A Labelle, D Addington, SR David, ... Archives of general psychiatry 57 (3), 249-258, 2000 | 652 | 2000 |
| Medication adherence of individuals with a first episode of psychosis EL Coldham, J Addington, D Addington Acta Psychiatrica Scandinavica 106 (4), 286-290, 2002 | 650 | 2002 |
| Neurocognitive and social functioning in schizophrenia J Addington, D Addington Schizophrenia bulletin 25 (1), 173-182, 1999 | 584 | 1999 |
| Facial affect recognition: a mediator between cognitive and social functioning in psychosis? J Addington, H Saeedi, D Addington Schizophrenia research 85 (1-3), 142-150, 2006 | 506 | 2006 |
| Neurocognitive and social functioning in schizophrenia: a 2.5 year follow-up study J Addington, D Addington Schizophrenia research 44 (1), 47-56, 2000 | 457 | 2000 |
| Cognitive functioning and positive and negative symptoms in schizophrenia J Addington, D Addington, E Maticka-Tyndale Schizophrenia research 5 (2), 123-134, 1991 | 457 | 1991 |
| Specificity of the Calgary Depression Scale for schizophrenics D Addington, J Addington, E Maticka-Tyndale Schizophrenia research 11 (3), 239-244, 1994 | 404 | 1994 |
| Guidelines for the pharmacotherapy of schizophrenia in adults G Remington, D Addington, W Honer, Z Ismail, T Raedler, M Teehan The Canadian Journal of Psychiatry 62 (9), 604-616, 2017 | 372 | 2017 |
| Smoking cessation treatment for patients with schizophrenia J Addington, N El-Guebaly, W Campbell, DC Hodgins, D Addington American Journal of Psychiatry 155 (7), 974-975, 1998 | 351 | 1998 |
| Social functioning in individuals at clinical high risk for psychosis J Addington, D Penn, SW Woods, D Addington, DO Perkins Schizophrenia research 99 (1-3), 119-124, 2008 | 350 | 2008 |
| A psychometric comparison of the Calgary depression scale for schizophrenia and the Hamilton depression rating scale D Addington, J Addington, M Atkinson Schizophrenia research 19 (2-3), 205-212, 1996 | 316 | 1996 |
| The first episode of psychosis: the experience of relatives J Addington, EL Coldham, B Jones, T Ko, D Addington Acta Psychiatrica Scandinavica 108 (4), 285-289, 2003 | 310 | 2003 |
| Influence of social perception and social knowledge on cognitive and social functioning in early psychosis J Addington, H Saeedi, D Addington The British Journal of Psychiatry 189 (4), 373-378, 2006 | 303 | 2006 |
| Duration of untreated psychosis: impact on 2-year outcome J Addington, S Van Mastrigt, D Addington Psychological medicine 34 (2), 277-284, 2004 | 272 | 2004 |
